Scientific programme

Thursday October 9

13:00–13:30 General assembly
Prof. Laurent Crenier (President), Prof. Guy T'Sjoen (Treasurer)

13:30–13:55 Registration & welcome coffee

13:55–14:00 Welcome address
Prof. Laurent Crenier

14:00–15:00 — Mastering pituitary tumor care: Overcoming management challenges based on expert insights

Sponsored by Recordati

Introduction: Prof. Orsalia Alexopoulou
14:05–14:30 Ectopic Cushing’s syndrome & aggressive pituitary tumors — Prof. Wouter de Herder (Erasmus MC)
14:30–14:55 Clinical cases: Cushing’s disease & aggressive prolactinoma — Dr. Stefan Matei Constantinescu
14:55–15:00 Q&A — Prof. Orsalia Alexopoulou

15:00–16:00 — European expert consensus on practical management of parathyroid disorders

Sponsored by Ascendis Pharma

Introduction: Dr. Sara Vandewalle
15:05–15:30 Hypoparathyroidism: physiology, etiology, patient journey — Dr. Charlotte Verroken (UZ Gent)
15:30–15:55 New treatment paradigms in hypoparathyroid disorders — Dr. Jean-Philippe Bertocchio (Paris)
15:55–16:00 Q&A — Dr. Sara Vandewalle

16:00–16:45 Coffee break, poster session & registration

16:45–17:00 Welcome address
Prof. Laurent Crenier

17:00–18:00 Diabetes and technology for inpatients
Prof. Julia Mader (Medical University of Graz)
Introduction: Prof. Roman Vangoitsenhoven

18:00–19:00 Impact of obesity on fertility
Prof. Christophe Blockeel (VUB)
Introduction: Prof. Robert Hilbrands

19:00–20:00 What can the European Reference Networks for Rare Endocrine Conditions mean to you and your patients?
Prof. Alberto Pereira Arias (Amsterdam UMC)
Introduction: Prof. Patrick Petrossians

20:00–22:00 Walking dinner

Friday October 10

08:00–08:30 Registration, poster session & exhibits

08:30–09:00 BSED in action: update on the diabetes convention, prevention & nomenclature update
Dr. Dominique Ballaux
Introduction: Prof. Guy T'Sjoen

09:00–10:00 — New options for treating kidney disease in diabesity

Sponsored by Novo Nordisk

Introduction: Prof. Roman Vangoitsenhoven
09:05–09:50 SGLT2i combination therapy with nsMRA and GLP1 — Prof. Peter Rossing (Steno Diabetes Center)
09:55–10:00 Q&A — Prof. Roman Vangoitsenhoven

10:00–11:15 “A breath of fresh air” — walking break

11:15–12:45 — Communications by young investigators

Sponsored by Pfizer
Introduction: Prof. Robert Hilbrands

Clinical & translational studies:

  • Real-world semaglutide effects on weight, glycemic control, and steatotic liver disease in type 1 diabetes — Dr. Jonathan Mertens (UZA)

  • Rapid on-site evaluation during thyroid fine-needle aspiration for sample quality — Dr. Aurelien Schommers (CHU Liège)

  • One-year hybrid closed-loop system effectiveness and safety in children aged 2–6 with type 1 diabetes — PhD Jolien Demeulemeester (KU Leuven)

  • HbA1c vs. continuous glucose monitoring disparities and microvascular complications in type 1 diabetes — Dr. Sarah Van Ostaeyen (UZA)

Clinical case reports:

  • Endoscopic ultrasound-guided radiofrequency ablation for left-sided aldosterone-producing adenoma — Dr. Lynda Bombil (UCL)

  • Familial hyperaldosteronism type I: long-read DNA sequencing contribution — Dr. Laura Abdessater (ULB)

12:45–13:30 Lunch

13:30–13:45 — Selected Belgian Publication Award

Sponsored by Sandoz
Introduction: Dr. Laura Iconaru

Thiazide challenge test for primary vs. hypercalciuria-related hyperparathyroidism — Dr. Ewout Verly, Prof. Bruno Lapauw & Dr. Charlotte Verroken (UZ Gent)

13:45–14:15 — Belgian Endocrine Society Lecture Award

Sponsored by Novo Nordisk
Introduction: Prof. Laurent Crenier

Changing landscape in steroid hormone assessment — Prof. Leen Antonio (KU Leuven)

14:15–14:45 Invited lecture: Thrombotic risk across sexual hormone treatment
Prof. Cédric Hermans (Cliniques universitaires Saint-Luc)
Introduction: Prof. Orsalia Alexopoulou

14:45–15:00 Young investigators award ceremony
Moderated by Prof. Laurent Crenier